Hikma Pharmaceuticals/£HIK

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Hikma Pharmaceuticals

Hikma Pharmaceuticals is a multinational pharmaceutical company headquartered in London, United Kingdom. It specializes in the development, manufacturing, and marketing of a broad portfolio of branded and non-branded generic and in-licensed pharmaceutical products. The company operates across three main segments: Injectables, Generics, and Branded, serving hospitals, pharmacies, and wholesalers. Hikma was founded in 1978 in Amman, Jordan, and has since expanded its operations globally, maintaining a significant presence in the Middle East and North Africa, the United States, and Europe. Its strategic positioning is supported by its extensive manufacturing capabilities and a strong commitment to quality and regulatory compliance.

Ticker

£HIK
Sector

Primary listing

LSE

Employees

9,500

HIK Metrics

BasicAdvanced
£4.1B
14.87
£1.24
0.60
£0.63
3.41%

What the Analysts think about HIK

Analyst ratings (Buy, Hold, Sell) for Hikma Pharmaceuticals stock.

Bulls say / Bears say

H1 2025 revenue increased 6% year-on-year to $1.658 billion, thanks to strong demand across all divisions and regions. (Reuters via TradingView)
Hikma remained one of the top three suppliers by volume of generic sterile injectables in the U.S., reinforcing its leadership in a high-margin market segment. (Reuters via TradingView)
The company established seven new strategic partnerships in H1 2025, including an exclusive licensing deal for rucaparib in MENA, boosting its Branded oncology business. (Reuters via TradingView)
Data summarised monthly by Lightyear AI. Last updated on 30 Sept 2025.

HIK Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

HIK Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £HIK

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs